Transcranial Magnetic Stimulation (TMS) in Cancer Care: A Scoping Review of Safety and Efficacy [0.03%]
经颅磁刺激(TMS)在癌症治疗中的应用：安全性和有效性的系统综述研究
Marie McLaughlin,Ethan Berry,Nilihan N E M Sanal-Hayes
Marie McLaughlin
Cancer remains a growing global health burden, with many survivors experiencing significant psychological symptoms such as fatigue, pain, anxiety, and depression. Noninvasive brain stimulation techniques such as rTMS have gained attention f...
Integrating Genomic Data and Imaging in Lung Cancer Prediction Using a Hybrid Deep Learning Approach [0.03%]
基于混合深度学习方法的肺癌预测中的基因组数据及影像整合研究
Anand Sharma,Narendra M Kandoi
Anand Sharma
Objectives: Lung cancer remains one of the leading causes of cancer-related mortality worldwide, underscoring the urgent need for improved diagnostic and predictive methodologies. The several challenges in the complexity ...
AI-Enabled Early Detection of Chemo-Induced Cardiotoxicity Patterns Using ECG Time Series Data: A Simulated Oncology Framework [0.03%]
基于ECG时间序列数据的AI辅助化疗诱导的心脏毒性的早期检测：模拟肿瘤学框架
Kamal Upreti,Jossy P George,Khushboo Malik et al.
Kamal Upreti et al.
Objectives: Chemotherapy-induced cardiotoxicity is still a major clinical problem, usually appearing subclinically before structural or symptomatic cardiac dysfunction appears. Standard surveillance methods use imaging an...
Accurate Lung Cancer Prediction From CT Scans Using Advanced Deep Learning Methods [0.03%]
基于先进深度学习方法的CT肺癌预后诊断
Anand Sharma,Narendra M Kandoi
Anand Sharma
Objectives: Accurate lung cancer prediction from CT scans using advanced deep learning methods is crucial for improving early diagnosis and treatment outcomes, as it harnesses innovative algorithms to enhance the detectio...
Deep Learning-Based Risk Factor Analysis for Accurate Prediction of Lung Cancer in High-Risk Populations [0.03%]
基于深度学习的肺癌高危人群风险因素分析及准确预测模型研究
Anand Sharma,N M Kandoi
Anand Sharma
Objectives: Lung cancer remains a leading cause of cancer-related deaths worldwide, largely due to late diagnosis and the complexity of its risk factors. Early detection and accurate risk prediction are critical to improv...
Genetic Alterations in NSCLC: Prognostic Implications and Impact on Therapeutic Resistance [0.03%]
非小细胞肺癌的遗传改变：预后价值和对治疗抵抗性的影响
Bhardwaj Tina Neelesh,Kanchan Bhardwaj,Phani Mn et al.
Bhardwaj Tina Neelesh et al.
Worldwide, the incidence of lung cancer is projected to continue its upward trend, with an estimated 2.5 million new cases annually. Non-small cell lung cancer (NSCLC) is the most prevalent form of lung cancer, accounting for ~85% of all ca...
Outcomes of Patients With Esophageal and Gastric Carcinoma at a Safety-net Health Care System: A Juncture to Explore Disparities in Diverse Socioeconomic Cohorts and Ethnicities [0.03%]
安全网医疗体系中食管和胃癌患者的预后：探索不同社会经济群体和族裔差异的切入点
Kalyani Narra,Sachita Guthula,Kari J Teigen et al.
Kalyani Narra et al.
Objectives: Outcomes for upper gastrointestinal (UGI) cancers are poor except for those patients whose cancers are diagnosed at a very early stage. Unique socioeconomic factors may result in worse outcomes in the safety-n...
Efficacy and Safety of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis [0.03%]
免疫检查点抑制剂治疗肝细胞癌的疗效和安全性：系统评价和 meta 分析
Muhammad A B Naeem,Muhammad R Paracha,Ahmad Noor et al.
Muhammad A B Naeem et al.
Objectives: Previous meta-analyses have assessed the benefits and safety profile of immune checkpoint inhibitors in hepatocellular carcinoma patients. This meta-analysis provides an updated synthesis by incorporating the ...
Comorbidity and Risk of Complications and Readmissions Following Surgery for Patients With Renal Cell Carcinoma in the Military Health System [0.03%]
军事卫生系统中肾细胞癌手术患者的合并症与并发症和再入院风险
Yvonne L Eaglehouse,Sarah Darmon,Jie Lin et al.
Yvonne L Eaglehouse et al.
Objectives: The effect of comorbidity on kidney and urinary complications after surgery for renal cell carcinoma (RCC) is unclear. We aimed to assess the effect of comorbidity on postoperative complications and readmissio...
Ahmed Abdelmonem,Bidhan Bikram Shah,Mouza Al Shebli et al.
Ahmed Abdelmonem et al.
Lung cancer is the leading cause of cancer-related mortality worldwide, with non-small cell lung carcinoma (NSCLC) comprising over 85% of cases. Advances in molecular diagnostics and precision oncology have shifted treatment toward mutation...